About this trial
This study will evaluate whether an artificial intelligence (AI)-driven dynamic health management strategy can help prevent ischemic stroke in adults at high risk of stroke. Participants will be identified through community-based screening in Beijing using the AI-ExpoStroke model together with established stroke risk factors.
Communities will be randomly assigned to either an AI-driven health management group or a usual community-based health management group. Participants in the AI-driven group will receive continuous health management supported by a digital platform, mobile applications or WeChat-based tools, wearable-device data when available, personalized health guidance, and remote support from community health care providers. Participants in the usual-care group will receive routine community health services, including health examinations, health education, chronic disease follow-up, and medication guidance.
Participants will be followed for 36 months. The main goal is to determine whether AI-driven health management reduces the occurrence of first-ever ischemic stroke. The study will also evaluate transient ischemic attacks, stroke-related disability, mortality, control of major vascular risk factors, adherence to health management, and health economic outcomes.
Eligibility criteria
Qualifiers
Age 30 years or older, with no restriction on sex. Permanent resident of Beijing. No previously diagnosed stroke based on prospective community screening. Identified as being at high risk of stroke by the AI-ExpoStroke model in combination with the established stroke "8+2" high-risk factors.
Disqualifiers
Previous diagnosis of ischemic stroke or hemorrhagic stroke. Severe cognitive impairment. Severe organic disease, including malignant tumors, heart failure of NYHA class III or higher, renal failure, or other severe conditions.
Trial design
Treatments tested in this trial
- Usual Community-Based Health Management
- AI-Driven Dynamic Health Management